C4X Discovery Holdings (C4XD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 17.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 37.00
  • 52 Week Low: 16.63
  • Currency: UK Pounds
  • Shares Issued: 252.12m
  • Volume: 5,089
  • Market Cap: 44.75m

C4XD Overview

C4X Discovery (C4XD) is a pioneering Drug Discovery company combining scientific expertise with cutting-edge Drug Discovery technologies to efficiently deliver world leading medicines, which are developed by our partners for the benefit of patients.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -389.8% -470.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 16.6 16.8
Pr/Book 3.8  
Latest F'cast
Revenue -52.2% -3.7%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

C4XD Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Jul-18 7.06 (2.53) (2.31)p n/a n/a n/a n/a 0.0%
31-Jul-19 n/a (13.62) (18.60)p n/a n/a n/a n/a 0.0%
31-Jul-20 n/a (9.58) (8.10)p n/a n/a n/a n/a 0.0%
31-Jul-21 5.64 (5.91) (1.96)p n/a n/a n/a n/a 0.0%
31-Jul-22 2.70 (10.53) (3.57)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

C4XD Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Jul-23 2.60 (12.22) (4.40)p n/a n/a n/a 3.00p 0.0%
31-Jul-24 6.10 (9.44) (3.10)p n/a n/a n/a 6.00p 0.0%
31-Jul-25 6.80 (8.69) (2.92)p n/a n/a n/a 9.00p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

C4XD Company Announcements

Result of AGM 24-Jan-2023 11:47 RNS
MALT-1 Inhibitor Programme Update 19-Jan-2023 07:00 RNS
Nick Ray Appointed as Chief Scientific Officer 10-Jan-2023 07:00 RNS

Latest C4XD Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

C4XD Market Data

Currency UK Pounds
Share Price 17.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 37.00
52 Week Low 16.63
Volume 5,089
Shares Issued 252.12m
Market Cap 44.75m

C4XD Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.01% below the market average18.01% below the market average18.01% below the market average18.01% below the market average18.01% below the market average
61.4% below the sector average61.4% below the sector average61.4% below the sector average61.4% below the sector average61.4% below the sector average
Price Trend
80.02% below the market average80.02% below the market average80.02% below the market average80.02% below the market average80.02% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average
Income Not Available
Growth
22.74% below the market average22.74% below the market average22.74% below the market average22.74% below the market average22.74% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

C4XD Dividends

No dividends found

Trades for 02-Feb-2023

Time Volume / Share Price
16:11 4,700 @ 17.54p
08:03 389 @ 17.58p

C4XD Key Personnel

CEO Clive Dix
CFO Bradley Hoy

Top of Page